Abstract ISI
 (2021)

Safety and seroconversion rates of mRNA and inactivated vaccines against SARS-CoV-2 among patients with multiple sclerosis: A multicentric observational study

Ciampi E.; Galleguillos L.; Pelayo C.; Guzman J.; Garcia L.; Jürgensen, L; Guzman I.; Uribe-San-Martin R.; Soler B.; Cárcamo C